Ataxia–Telangiectasia — Broad Implications for a Rare Disorder
- 7 September 1995
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 333 (10) , 662-664
- https://doi.org/10.1056/nejm199509073331014
Abstract
Ataxia–telangiectasia is a rare autosomal recessive disorder with diverse clinical manifestations. Patients typically come to medical attention in early childhood because of ataxia, and this is followed by progressive neuromotor degeneration, usually resulting in dependence on a wheelchair by 10 years of age. In addition to cerebellar degeneration, patients with ataxia–telangiectasia have elevated levels of alpha-fetoprotein, various immunologic deficiencies, growth retardation, premature aging, chromosomal instability, an increased frequency of lymphoreticular cancers, and hypersensitivity to ionizing radiation and radiomimetic drugs.1 The defective gene responsible for this pleiotropic disorder (ATM) was recently identified by a multinational group led by investigators . . .Keywords
This publication has 4 references indexed in Scilit:
- A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 KinaseScience, 1995
- Phospholipid signalingCell, 1995
- Incidence of Cancer in 161 Families Affected by Ataxia–TelangiectasiaNew England Journal of Medicine, 1991
- Cancer predisposition of ataxia-telangiectasia heterozygotesCancer Genetics and Cytogenetics, 1990